LBA56 Updated Efficacy and Safety from the Phase II PHAROS Study of Encorafenib Plus Binimetinib in Patients with BRAF V600E-mutant Metastatic NSCLC (Mnsclc)

G.J. Riely,M-J. Ahn, J. Clarke,I. Dagogo-Jack,E. Felip,F. Gelsomino,J.W. Goldman, M. Hussein, M.L. Johnson,D. Morgensztern, E. Nadal,M.D. Offin, M. Provencio Pulla, S.S. Ramalingam, E.F. Smit,A.S. Tsao, A. Alcasid,T. Usari,K. Wilner, B. Johnson

Annals of Oncology（2024）

Cited 0|Views12

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined